Paitoon Rashatasakhon | Fluorescent Dyes | Innovative Research Award

Published on by Cell Biologist

Innovative Research Award

Paitoon Rashatasakhon
Chulalongkorn University, Thailand

Paitoon Rashatasakhon
Affiliation Chulalongkorn University
Country Thailand
Scopus ID 6603258134
Documents 88
Citations 2,123
h-index 28
Subject Area Fluorescent Dyes
Event World Cell Biologist Awards
ORCID 0000-0002-7993-7968

Paitoon Rashatasakhon is a researcher affiliated with Chulalongkorn University, Thailand, whose scholarly profile includes research associated with fluorescent dyes and related areas of chemical and biological applications. The recognition presented here is associated with the Innovative Research Award under the World Cell Biologist Awards. Bibliographic indicators such as publication counts, citation counts and the h-index are commonly used to describe aspects of a researcher’s scholarly output and citation impact.  [1]

Abstract

Paitoon Rashatasakhon is affiliated with Chulalongkorn University in Thailand and is identified in the supplied research profile with a subject-area focus on fluorescent dyes. The profile records 88 documents, 2,123 citations and an h-index of 28. Fluorescent dyes constitute an important research domain because fluorescent molecules can provide sensitive optical signals for analytical chemistry, molecular recognition, imaging and biological investigation. [2] The Innovative Research Award recognizes research activity presented in the context of the World Cell Biologist Awards, with this profile emphasizing bibliographic output, citation impact and relevance to fluorescence-based research.

Keywords

Innovative Research Award; Paitoon Rashatasakhon; Chulalongkorn University; Fluorescent Dyes; Fluorescence Chemistry; Molecular Probes; Bioimaging; Research Impact

Introduction

Fluorescence-based methods occupy an important position across modern chemical and life-science research. Fluorescent dyes and probes can convert molecular interactions or environmental changes into measurable optical signals, supporting applications that range from chemical sensing to cellular and molecular imaging. [2] The development of fluorescent probes has also contributed to the investigation of biological processes where spatial and temporal information is important.

Research Profile

The supplied profile identifies Paitoon Rashatasakhon as a researcher at Chulalongkorn University, Thailand, with a research focus associated with fluorescent dyes. The stated Scopus record contains 88 documents, 2,123 citations and an h-index of 28. The corresponding Scopus author identifier is 6603258134. [1]

Research Contributions

Research involving fluorescent dyes may contribute to the development of molecules and analytical strategies capable of generating detectable optical responses. Depending on molecular design and application, fluorescent systems can be used to investigate chemical environments, molecular interactions and biological phenomena. [2] Fluorescent probes are also relevant to biological research because appropriately designed fluorophores can provide information about cellular structures, biochemical events and molecular targets. The field therefore intersects chemistry, analytical science, molecular biology and cell biology. [4]

Publications

The supplied profile reports 88 documents indexed in Scopus. [1] A complete publication bibliography should be retrieved directly from the researcher’s current institutional and bibliographic profiles because publication lists, citation counts and indexing records can change over time.

For scholarly evaluation, publications in fluorescent-dye research can encompass synthetic chemistry, photophysical characterization, sensing, molecular recognition, imaging and applications in biological systems. Fluorescent probes have been extensively studied for their ability to provide optical responses to specific chemical or biological conditions. [3]

Research Impact

The supplied bibliometric profile records 2,123 citations and an h-index of 28 across 88 documents. [1] These figures indicate measurable citation activity associated with the indexed publication record. Citation-based indicators are most appropriately considered alongside the quality, originality, relevance and reproducibility of the underlying research.[4]

Research on fluorescent systems may also support the development of probes with improved selectivity, sensitivity and photophysical characteristics. Such advances can be relevant to chemical sensing, molecular diagnostics and imaging-oriented research, depending on the intended application and validation of each system. [5]

Award Suitability

The Innovative Research Award profile is aligned with the supplied research information concerning Paitoon Rashatasakhon, particularly the stated subject area of fluorescent dyes and the documented bibliographic indicators. The relationship between fluorescent-dye chemistry and cell biology provides an interdisciplinary basis for considering research that contributes methods, probes or analytical approaches applicable to biological investigation.

Conclusion

Paitoon Rashatasakhon of Chulalongkorn University, Thailand, is presented in the supplied profile as a researcher working in the area of fluorescent dyes. The profile reports 88 documents, 2,123 citations and an h-index of 28. Fluorescent-dye research occupies an interdisciplinary position connecting chemical design, analytical measurement and biological investigation. [2]

References

  1. Elsevier. (n.d.). Scopus author details: Paitoon Rashatasakhon, Author ID 6603258134. Scopus.
    https://www.scopus.com/pages/authors/6603258134
  2. S Namuangruk, P Rashatasakhon., et al. (2020). Solvatochromic triazaborolopyridinium probes toward ultra-sensitive trace water detection in organic solvents.
    https://www.sciencedirect.com/science/article/pii/S0143720820304654
  3. M Sukwattanasinitt, P Rashatasakhon., et al. (2021). Fluorescent sensor for copper (II) and cyanide ions via the complexation–decomplexation mechanism with di (bissulfonamido) spirobifluorene.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8246698/
  4. P Rashatasakhon, T Kumchoo, V Promarak, et al. (2010). Dipyrenylcarbazole Derivatives for Blue Organic Light‐Emitting Diodes.
    https://www.academia.edu/download/45727478/asia.20100030420160517-24947-14faydz.pdf
  5. P Chinapang, V Ruangpornvisuti, M Sukwattanasinitt, P Rashatasakhon. (2015). Ferrocenyl derivative of 1, 8-naphthalimide as a new turn-on fluorescent sensor for Au (III) ion.
    https://www.sciencedirect.com/science/article/pii/S0143720814002903

Ana Estela | Developmental Cell Biology | Women Researcher Award

Published on by Cell Biologist

Dr. Ana Estela | Developmental Cell Biology | Women Researcher Award

UNSE | Argentina

Ana Estela Ledesma is a senior researcher specializing in macromolecules, biomolecular interactions, and nanosystems, combining theoretical calculations with advanced spectroscopic techniques. Her work focuses on elucidating structural and biophysical mechanisms in protein–ligand and protein–surface interactions. She has led and contributed to numerous nationally funded research projects and has an extensive publication record in indexed journals. Her research spans nanoparticles functionalized with natural compounds for medical and agricultural applications, bioactive alkaloids with hypoglycemic effects, oxidative processes in proteins, and the characterization of probiotic and prebiotic biomolecules.

Citation Metrics (Scopus)

700
600
400
200
100
50
0

Citations
613

Documents
38

h-index
15

Citations

Documents

h-index

Featured Publications

Mohamed Dammak | Cell Structure Analysis | Best Academic Researcher Award

Published on by Cell Biologist

Prof. Dr. Mohamed Dammak | Cell Structure Analysis | Best Academic Researcher Award

Faculty of Sciences of Sfax | Tunisia

Professor Mohamed Dammak is a distinguished researcher in the field of chemistry, recognized for his significant contributions to materials science, solid-state chemistry, and nanomaterials. His research primarily focuses on the synthesis, structural characterization, and optical properties of functional materials, including luminescent phosphors, glass ceramics, and doped oxide systems. He has extensively investigated rare-earth-doped materials for photonic and optoelectronic applications, contributing valuable insights into energy transfer mechanisms and material stability under various conditions. Professor Dammak’s scholarly output includes numerous publications in high-impact journals indexed in SCI and Scopus, reflecting his consistent pursuit of scientific excellence. With over 1,100 citations and an h-index of 17, his work has had a measurable influence on contemporary research in materials chemistry. He has also participated in national and international research collaborations, enhancing cross-disciplinary approaches to the development of advanced materials with optical and structural functionalities. Through his academic leadership and commitment to innovation, Professor Dammak continues to advance the understanding and application of inorganic and functional materials, bridging the gap between fundamental research and technological development in the field of chemistry.

Profile: Scopus

Featured Publications:

Dammak, M.*, Abdelmoula, N., Cheikhrouhou-Koubaa, W., & Cheikhrouhou, A. (2021). Short-range magnetic behavior in manganites La₀.₉₃K₀.₀₇Mn₁₋ₓCuₓO₃ (0.0 ≤ x ≤ 0.09) above the Curie temperature. Journal of Physics D: Applied Physics, 54(32), 325002. https://doi.org/10.1088/1361-6463/ac015c

 

Muhammad Junaid Anwar | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Dr. Muhammad Junaid Anwar | Immunology Cellular Interactions | Best Researcher Award

Bahauddin Zakariya Univeristy |Pakistan

Dr. Muhammad Junaid Anwar is a rising scholar in Food Science & Technology whose work spans bioactive compounds, dairy protein‐based nanoencapsulation, food safety, and nutraceutical applications. According to Google Scholar, he has authored over 20 peer-reviewed articles and accumulated more than 270 citations to date, reflecting an h-index of 8.  His research includes investigations into olive oil polyphenols for cancer prevention, development of casein-based nanoencapsulation for managing cow’s milk allergy, optimization of ultrasonication pre-treatments for microbial reduction in fresh produce, and exploration of isoflavones and resveratrol in anticancer contexts. Through a blend of experimental and review work, he advances both the applied and mechanistic understanding of functional foods and health-promoting ingredients.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Anwar, M. J., Anwar, M. H., Imran, M., Noman, A. M., Hussain, M., Raza, H., … & Selim, S. (2025). Olive oil polyphenols: A promising approach for cancer prevention and therapy. Food Science & Nutrition, 13(9), e70976.

Anwar, M. J., Hameed, A., Khan, M. U., Mazhar, A., & Manzoor, H. M. I. (2025). Development and exploration of casein-based nano-encapsulation of mangiferin for cow milk allergy management and immunomodulation. Food Bioscience, 66, 106278.

Javed, M. S., Nawaz, H., Filza, F., Anwar, M. J., Shah, F. U. H., Ali, U., … & Nayik, G. A. (2025). Optimization of calcium chloride and ultrasonication pre-treatment to mitigate the microbial load on fresh carrots using response surface methodology. Ultrasonics Sonochemistry, 116, 107311.

Ul Hassan, M. H., Shahbaz, M., Imran, M., Momal, U., Naeem, H., Mujtaba, A., Hussain, M., Anwar, M. J., Alsagaby, S. A., Al Abdulmonem, W., Yehuala, T. F., & Mostafa, E. M. (2025). Isoflavones: Promising natural agent for cancer prevention and treatment. Food Science & Nutrition, 13(3), e70091.

Hameed, A., Ashraf, F., Anwar, M. J., Amjad, A., Hussain, M., Imran, M., … & Jbawi, E. A. (2024). α-Amylase enzyme inhibition relevant to type II diabetes by using functional yogurt with Cinnamomum verum and Stevia rebaudiana. Food and Agricultural Immunology, 35(1), 2389091.

Khalid, M. U., Sultan, M. T., Khan, W. A., Israr, M., Zafar, N., Noman, A. M., Imtiaz, S., Younis, M., Anwar, M. J., Nayyar, A., Orabi, A. A., & Khalil, N. A. (2024). Nutritional and physico-chemical profiling of Tribulus terristris and its nutraceuticals application. Journal of Population Therapeutics & Clinical Pharmacology, 31(9), 1230–1241.

Faisal, Z., Irfan, R., Akram, N., Manzoor, H. M. I., Aabdi, M. A., Anwar, M. J., … & Desta, D. T. (2024). The multifaceted potential of fenugreek seeds: From health benefits to food and nanotechnology applications. Food Science & Nutrition, 12(4), 2294–2310.

Javed, M. S., Alvi, S. Q., Amjad, A., Sardar, H., Anwar, M. J., Javid, A., … & AbdElgawad, H. (2024). Protein extracted from Moringa oleifera Lam. leaves: Bio-evaluation and characterization as suitable plant-based meat-protein alternative. Regulatory Toxicology and Pharmacology, 146, 105536.

Anwar, M. J., Altaf, A., Imran, M., Amir, M., Alsagaby, S. A., Al Abdulmonem, W., Mujtaba, A., El-Ghorab, A. H., Ghoneim, M. M., Hussain, M., Al Jbawi, E., Shaker, M. E., & Abdelgawad, M. A. (2023). Anti-cancer perspectives of resveratrol: A comprehensive review. Food and Agricultural Immunology, 34(1).

Hameed, A., Anwar, M. J., Khan, M. I., Tarar, O. M., Ali, S. W., Faraz, A., … & Kashif, A. S. (2023). Assessing the impact of camel breed and their grazing habits on the nutritional profile of milk. Pakistan Journal of Agricultural Sciences, 60(2).

Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

The Ohio State University | United States

Dr. Ann-Kathrin Eisfeld is an internationally recognized physician-scientist and Associate Professor with Tenure in the Division of Hematology at The Ohio State University, where she also serves as Director of the Clara D. Bloomfield Center for Leukemia Outcomes Research. Her research focuses on the molecular and genetic underpinnings of acute myeloid leukemia (AML), with a particular emphasis on translational applications that improve patient outcomes. Dr. Eisfeld has published extensively in high-impact journals such as Nature, Leukemia, Blood, and Cell Stem Cell, contributing significantly to our understanding of leukemia biology, clonal evolution, and treatment resistance. she has authored over 100 peer-reviewed scientific publications, with an h-index of 38, more than 6,500 citations, and has led or co-led multiple collaborative studies within national consortia such as the Alliance for Clinical Trials in Oncology. Her work has identified critical biomarkers and therapeutic targets in AML, including insights into TP53 mutations, FLT3 alterations, and resistance mechanisms to venetoclax. Recognized for her integration of clinical insight with cutting-edge genomics, Dr. Eisfeld is a leading voice in precision oncology and leukemia research, shaping the future of individualized treatment strategies through both clinical innovation and scientific discovery.

Profile: Scopus

Featured Publications:

“Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading?”

“Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia”

“miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia”

“Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia”

“Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation”

“inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations”

“Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients”

“In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline”

“A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia”

Emine Mine Soylu | Plant Pathology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Emine Mine Soylu | Plant Pathology | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Emine Mine Soylu is a prominent academic in the field of plant pathology, with a career spanning over three decades dedicated to plant protection, host-pathogen interactions, and disease management strategies in crops. She began her professional journey as a Research Assistant at Akdeniz University and has since contributed significantly to scientific research through both experimental studies and scholarly publications. Her work is widely recognized, with a particular focus on the identification and control of fungal and bacterial diseases in economically important plants. Prof. Soylu has published 54 scientific documents in internationally refereed journals and has amassed a total of 3,749 citations, reflecting the substantial impact of her work in the field. Her h-index is 25, indicating consistent and high-quality contributions to science over the years. Her research includes first reports of various plant diseases in Türkiye and in-depth studies on disease resistance mechanisms and biochemical plant responses. Prof. Soylu’s contributions continue to shape the future of sustainable agriculture and plant health, and her collaborations extend across national and international scientific communities. Her scholarly output and citation metrics demonstrate her strong influence in the field of phytopathology and plant-microbe interactions.

Profiles: Google Scholar | Scopus |  Orcid

Featured Publications:

  • “Preliminary Characterization of Race-Specific Elicitors From Peronospora parasitica and Its Ability to Elicit Phenolic Accumulation in Arabidopsis”

  • “First Report of Downy Leaf Spot of Walnuts Caused by Microstroma juglandis in Turkey”

  • “Induction of Disease Resistance by the Plant Activator, Acibenzolar-S-methyl (ASM), Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato Seedlings”

  • “First Report of Powdery Mildew Caused by Erysiphe heraclei on Dill (Anethum graveolens) in Turkey”

  • “Light and Electron Microscopy of the Compatible Interaction Between Arabidopsis and the Downy Mildew Pathogen Peronospora parasitica”

  • “Induction of Defence Related Enzymes and Resistance by the Plant Activator Acibenzolar-S-methyl in Tomato Seedlings Against Bacterial Canker Caused by Clavibacter michiganensis subsp. michiganensis”

  • “First Report of Cercospora Leaf Spot on Swiss Chard Caused by Cercospora beticola in Turkey”

  • “First Report of Phloeospora Leaf Spot on Mulberry Caused by Phloeospora maculans (=Cylindrosporium maculans) in the Eastern Mediterranean Region of Turkey”

  • “Induction of Disease Resistance and Antioxidant Enzymes by Acibenzolar-S-methyl Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato”

  • “First Report of Powdery Mildew Caused by Podosphaera phaseoli (syn. Sphaerotheca phaseoli) on Cowpea (Vigna sinensis) in Turkey”

 

 

 

 

 

 

 

 

 

 

Marwa Aly | Bacterial Extracellular Vesicles | Best Researcher Award

Published on by Cell Biologist

Dr. Marwa Aly | Bacterial Extracellular Vesicles | Best Researcher Award

Dr. Marwa Aly | HB Fuller | United States

Dr. Marwa Aly (published as Marwa Gamal Saad), Ph.D., is a Senior Scientist at H.B. Fuller Company with an impressive interdisciplinary background spanning microbiology, bioengineering, nanotechnology, and biotechnology. She holds dual Ph.D. degrees from Port Said University (with research at Texas A&M University) and Washington State University, where she recently completed a thesis on bacterial extracellular vesicles targeting drug-resistant pathogens. Dr. Aly has authored multiple high-impact publications, secured substantial research funding, and contributed to patent-pending technologies. Her innovative work bridges the gap between microbial research and real-world applications, such as alternative biofuels and novel antimicrobials. With an h-index of 6 and over 250 citations, she has demonstrated consistent scientific impact. Recognized by prestigious awards like the Cougar Cage Award and WSU President’s Leadership Award, Dr. Aly is an emerging thought leader in microbial biotechnology, making her a prime candidate for the Best Researcher Award.

Publication Profiles:

Google Scholar
Scopus
Orcid

Education:

Dr. Marwa Aly holds two Doctor of Philosophy degrees in advanced scientific disciplines. She earned her first Ph.D. in Botany from Port Said University, Egypt, with collaborative research at Texas A&M University, USA. Her research focused on sustainable biofuel production from microalgae using nanotechnology and genetic engineering. She recently completed a second Ph.D. in Engineering from Washington State University, USA. Her dissertation investigated bacterial extracellular vesicles and their potential as next-generation antimicrobials against drug-resistant pathogens. Dr. Aly’s dual doctoral qualifications reflect her interdisciplinary expertise and commitment to solving complex global challenges. Her educational journey is marked by innovation, academic rigor, and successful translation of research into real-world impact.

Research Experience:

As a Graduate Assistant at Washington State University in Dr. Wen-Ji Dong’s Lab, Dr. Aly has pioneered research on microbial extracellular vesicles (EVs), securing a provisional patent and winning $100,000 in Cougar Cage funding. Her work involves in vitro and in vivo analysis of EVs from Pseudomonas aeruginosa, exploring their antimicrobial action, especially against Candida auris and drug-resistant pathogens. She also studies the role of ferroptosis in EV-mediated treatment strategies and has led proteomic profiling of bacterial biofilms. In her earlier Ph.D. work, she developed methods for microalgae-based biodiesel production using advanced microfluidics and nanotechnology. Her multidisciplinary research blends microbiology, chemical engineering, and biotechnology to address critical challenges in public health and sustainable energy. Her scientific contributions are recognized globally, making her a strong contender for research excellence.

Awards and Honors:

Dr. Marwa Aly has received multiple prestigious accolades recognizing her leadership, innovation, and research excellence. She was a winner of the ISEV Image Competition, celebrating creativity in extracellular vesicle research. She received the Cougar Cage Award from Washington State University for her promising EV-based antimicrobial proposal. Her leadership and academic excellence earned her the WSU President’s Award for Leadership and recognition as a WSU Woman of Distinction. These awards highlight not only her scientific contributions but also her dedication to community engagement, mentorship, and cross-disciplinary collaboration. Her ability to secure competitive funding, publish impactful research, and innovate at the intersection of biology and engineering underscores her qualifications for the Best Researcher Award.

Research Focus:

Dr. Marwa Aly’s research centers on extracellular vesicles (EVs) and their potential to combat antimicrobial resistance. Her recent focus is on stage-dependent EVs produced by Pseudomonas aeruginosa and algae, exploring their ability to disrupt biofilms and trigger ferroptosis in pathogenic organisms. Her research includes proteomic analysis, biofilm interaction studies, and in vivo wound infection models, advancing the understanding of EVs as therapeutic agents. Additionally, she has conducted microfluidic-based studies for biofuel optimization, developing innovative devices to study microalgae growth under various environmental conditions. Her work is grounded in translational science, bridging lab discoveries with industrial applications such as bioenergy and infection control. By integrating microbiology, bioengineering, and nanotech, she is at the forefront of next-generation biotechnologies, making substantial contributions to public health, sustainability, and microbial sciences.

Publications Top Notes:

  1. Algal Biofuels: Current Status and Key Challenges – Energies

  2. Exosomes as Powerful Engines in Cancer: Isolation, Characterization and Detection Techniques – Biosensors

  3. Evaluation of Storage Stability for Biocrude Derived from Hydrothermal Liquefaction of Microalgae – Energy & Fuels

  4. High-Throughput Screening of Chlorella Vulgaris Growth Kinetics in Microfluidics – Biomolecules

  5. Droplet-based Microfluidic Gradient for Chlorella Growth under Nitrogen & Temp Stress – Algal Research

  6. Impact of Nitrogen Regime on Fatty Acid Profiles of Algae for Biofuel – Acta Botanica Hungarica

  7. Dual Roles of Conditional Extracellular Vesicles from Pseudomonas Biofilms – Biofilm

  8. Phytochemical Screening and Antimicrobial Activity of Egyptian Green Algae – Journal of Medicinal Plants Studies

  9. Nitrogen Concentration Impact on Algal Biomass, Lipids & Biofuel Yield – IJSTR

  10. Challenges of Biodiesel Production from Oscillatoria sp. – IJAR

Conclusion:

In conclusion, Dr. Marwa Aly (Marwa Gamal Saad) is a highly qualified, driven, and impactful researcher who has made significant contributions across several vital scientific areas, from microbial therapeutics to renewable biofuels. Her dual-Ph.D. credentials, publication record, patent-pending research, competitive grant success, and multiple recognitions make her an excellent candidate for the Best Researcher Award. While she can further enhance her profile through increased international engagement and publication output, her current achievements already distinguish her as a rising leader in the fields of biotechnology, microbiology, and bioengineering. She is not only suitable but highly recommended for this recognition.

yu chen | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Prof. yu chen | Molecular Mechanisms Signaling | Best Researcher Award

Prof. yu chen , Chengdu University of Technology , China

Prof. Yu Chen is a leading researcher in the field of perovskite solar cells, with a particular emphasis on interfacial engineering and charge transport materials. He is currently a Principal Investigator at the Chengdu University of Technology, College of Materials and Chemistry & Chemical Engineering. His academic journey spans top institutions in China, culminating in a Ph.D. from Nanjing University of Science and Technology under the guidance of Prof. Shenli Zhang and Prof. Wenhua Zhang. Prof. Chen has co-authored numerous high-impact journal articles, including in Nature Communications, Advanced Materials, and Chemical Engineering Journal, significantly contributing to the field of renewable energy. His innovative approaches to improving stability and efficiency in perovskite photovoltaics have earned him national recognition. Prof. Chen’s work blends academic rigor with practical innovation, aiming to push the boundaries of solar cell technologies toward commercial viability and sustainability.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  • High-impact Publications: Prof. Chen has published extensively in top-tier journals such as Nature Communications, Advanced Materials, Angewandte Chemie, and Advanced Functional Materials, indicating global recognition and scientific rigor.

  • Cutting-edge Research Focus: His work on perovskite solar cells, especially on buried interface engineering, inorganic transport layers, and molecular self-assembly, addresses fundamental and applied challenges in next-generation photovoltaic technologies.

  • Innovation & Application: Techniques like guanylation reaction for MACl removal and ion compensation strategies demonstrate a deep understanding of material-device interplay and have direct implications for industrial application.

  • Leadership & Funding: As a Principal Investigator at Chengdu University of Technology, leading national-level projects (e.g., Qomolangma Talent Program), Prof. Chen has proven both scientific leadership and funding competitiveness.

  • International Collaboration: His co-authorship with global leaders such as Prof. Shengzhong Liu and Prof. Wenhua Zhang strengthens his international research presence.

⚠️ Areas for Improvement:

  • Broader Research Diversification: While his specialization in perovskites is a clear strength, expanding into hybrid systems (e.g., tandem solar cells with silicon or organic-inorganic integration) could elevate his interdisciplinary impact.

  • Industry Partnership: Greater collaboration with industrial partners or startups could accelerate the commercial translation of his innovations.

  • International Fellowships or Visiting Positions: Engaging in international academic exchanges or fellowships (e.g., Marie Curie, Humboldt) could further enhance global visibility.

🎓 Education:

Prof. Yu Chen completed his Ph.D. in Materials Science from Nanjing University of Science and Technology (2019–2023) under the supervision of Prof. Shenli Zhang and Prof. Wenhua Zhang. During this period, he focused on advanced interfacial design and ion migration in perovskite solar cells. He earned his M.Eng. in Chemical Engineering from Changzhou University (2016–2019), mentored by Prof. Ningyi Yuan and Prof. Wenhua Zhang, where he laid the foundation for his research on inorganic materials. His academic journey began with a B.Eng. in Materials Science from Pujiang University (2012–2016), under the supervision of Prof. Jian Huang. This strong and progressive academic background empowered Prof. Chen with a multi-scale understanding of materials synthesis, structural engineering, and device-level optimization — skills now central to his research on high-efficiency photovoltaic technologies.

💼 Experience:

Since 2023, Prof. Yu Chen has been serving as a Principal Investigator at Chengdu University of Technology’s College of Materials and Chemistry & Chemical Engineering. He leads a research group focused on developing next-generation perovskite solar cells, emphasizing stable, efficient, and scalable photovoltaic systems. Prof. Chen has developed several novel techniques involving inorganic hole/electron transport layers and interfacial dipole engineering. His experience spans fundamental research, technology translation, and academic collaboration with prestigious researchers such as Prof. Shengzhong Liu and Prof. Yihui Wu. He is also the recipient and presiding investigator of projects like the “Qomolangma Talent Introduction Program” and the Youth Foundation of Sichuan Natural Science Foundation. His role combines leadership, mentorship, and high-level experimental research, making him an influential figure in China’s renewable energy academic landscape.

🏅 Awards and Honors:

Prof. Yu Chen has received several prestigious accolades for his outstanding contributions to solar cell research. In 2019, he was honored with the “Excellent Wall Poster Award” at the China Material Conference, recognizing his innovative visualization of research. In 2023, he earned the title of “Outstanding Graduate” from the China Academy of Engineering Physics, showcasing both his academic excellence and research impact. As the Principal Investigator of prominent research programs such as the Qomolangma Talent Introduction Program, he has demonstrated leadership and vision. His work has been continuously supported by competitive grants, including the Youth Foundation of the Sichuan Natural Science Foundation. These honors reflect not only Prof. Chen’s personal achievements but also his potential to lead transformative advancements in solar energy technologies, particularly in high-efficiency, stable, and scalable perovskite solar cells.

🔬 Research Focus:

Prof. Yu Chen’s research focuses on the design and development of highly efficient and stable perovskite solar cells, with specific expertise in buried interface engineering, inorganic charge transport materials, and defect passivation strategies. His work emphasizes inverted perovskite solar architectures, which promise better long-term stability and commercial adaptability. A key aspect of his research is understanding how molecular self-assembly and interfacial dipole regulation can enhance charge extraction and minimize recombination losses. He has developed novel methods to remove residuals, such as MACl, and form stable 2D perovskite structures in situ, improving device performance. By integrating materials chemistry, device physics, and advanced fabrication, Prof. Chen addresses critical bottlenecks in the field. His research not only advances academic understanding but also aligns with industrial needs for reliable and sustainable photovoltaic technologies.

📚 Publication Top Notes:

  1. 🧪 Enlarging moment and regulating orientation of buried interfacial dipole for efficient inverted perovskite solar cells – Nature Communications, 2025

  2. ⚗️ High‐Efficiency Perovskite Solar Cells Enabled by Guanylation Reaction for Removing MACl Residual – Angewandte Chemie Int. Ed., 2025

  3. 🧬 Tailoring Buried Interface and Minimizing Energy Loss by Aluminum Glycinate Molecules – Advanced Materials, 2025

  4. 🧫 A regulation strategy of self-assembly molecules for achieving efficient inverted perovskite solar cells – PCCP, 2024

  5. 🧠 A Comprehensive Review of Organic Hole‐Transporting Materials for Inverted Perovskite Solar Cells – Advanced Functional Materials, 2024

  6. 🔍 Elimination of Buried Interface Defects for Efficient Wide-Bandgap Perovskite Solar Cells – Chinese Journal of Chemical Physics, 2023

  7. 🧱 Research Progress of Inorganic Hole Transport Materials in Perovskite Solar Cells – Journal of Inorganic Materials, 2023

  8. 🔋 Ion Compensation of Buried Interface Enables Efficient MA‐Free Perovskite Solar Cells – Advanced Functional Materials, 2022

  9. 💊 Defect mitigation using d-penicillamine for stable MA-free perovskite solar cells – Chemical Science, 2021

  10. ⚙️ Reducing carrier transport barrier in anode interface enables stable inverted mesoscopic perovskite solar cells – Chemical Engineering Journal, 2021

🔚 Conclusion:

Prof. Yu Chen stands out as a highly promising and already accomplished materials scientist. His strong academic record, innovative research on energy materials, leadership in national research programs, and consistent output in prestigious journals make him exceptionally qualified for the Best Researcher Award. While early in his career, his trajectory shows the hallmark of a future leader in clean energy research. With minor expansions in scope and outreach, Prof. Chen is poised to become a central figure in advancing sustainable photovoltaic technologies.

Balbino Alarcón | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Balbino Alarcón | Cancer Cell Biology | Best Researcher Award

Prof. Dr. Balbino Alarcón , Consejo Superior de Investigaciones Científicas , Spain

Balbino Alarcón is a leading Spanish immunologist renowned for his contributions to T cell biology and immune signaling. Currently serving as Profesor de Investigación at the Consejo Superior de Investigaciones Científicas (CSIC), he has been affiliated with the Centro de Biología Molecular Severo Ochoa since 2002. His research has played a pivotal role in uncovering mechanisms of T cell receptor (TCR) signaling and immune system regulation. Dr. Alarcón holds a PhD in Biology from the Universidad Autónoma de Madrid, where he began shaping his scientific journey in the early 1980s. Over the decades, he has authored numerous impactful publications, many in top-tier journals, and holds several patents licensed to biotech companies. His work bridges fundamental immunology with translational applications in autoimmunity and cancer. With a keen focus on molecular signaling, his research continues to influence both basic science and therapeutic innovation in immunology.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Outstanding Research Contributions:
    Dr. Alarcón has made seminal contributions to immunology, especially in T cell receptor (TCR) signaling, immune synapse formation, and immune cell communication. His work has appeared in top-tier journals like Cell, Immunity, Nature Communications, and Journal of Experimental Medicine.

  2. Impactful Publications & Citations:
    His research includes several highly cited papers (e.g., >500 citations), underlining the influence of his work on the broader scientific community.

  3. Translational Achievements:
    He holds multiple patents on immunomodulatory molecules (e.g., AX-024), which were licensed to biotech company Artax Biopharma, bridging basic science and clinical application.

  4. SARS-CoV-2 Research Leadership:
    He actively contributed to COVID-19 immunity research, developing flow cytometry-based antibody detection techniques and tracking longitudinal immune responses to infection and vaccination.

  5. Longevity and Commitment:
    Over 40 years of consistent research activity, with continuous affiliation to one of Spain’s most prestigious scientific institutions, CSIC.

  6. International Collaboration:
    He co-authored papers with leaders in immunology, showing global recognition and collaboration.

🛠️ Areas for Improvement:

  • Public Engagement & Visibility:
    Despite scientific acclaim, more visibility in public science communication, conference keynote roles, or leadership in global immunology consortia would further support his candidacy.

  • Mentorship Highlighting:
    While his academic stature suggests mentorship, documentation or awards for training young scientists could enhance his profile for broader awards recognizing holistic impact.

  • Innovation Metrics:
    Increased emphasis on clinical translation or successful product development from his patents could strengthen claims to innovation-driven recognitions.

🎓 Education:

Dr. Balbino Alarcón completed his undergraduate degree (Licenciado en Biología) in 1982 and his PhD in Biology with a specialization in Biochemistry in 1985, both from the Universidad Autónoma de Madrid, Spain. During his academic formation, he developed a deep interest in immunological signaling, particularly in how T cells communicate with their environment. His early education laid the foundation for a distinguished research career that has spanned more than three decades. His doctoral studies were focused on cellular and molecular immunology, equipping him with the tools to explore intricate signaling pathways. This robust educational background positioned him for leadership roles in immunological research, both nationally and internationally. Through rigorous academic training and continuous research contributions, Dr. Alarcón has become a key figure in advancing our understanding of T cell function and immune regulation.

👨‍🔬 Experience:

Dr. Balbino Alarcón has over 40 years of experience in immunological research, with a primary focus on T cell receptor (TCR) signaling and lymphocyte activation. Since July 27, 2002, he has held the position of Profesor de Investigación at the Consejo Superior de Investigaciones Científicas (CSIC), working at the Centro de Biología Molecular Severo Ochoa in Madrid, Spain. His academic and research career began with groundbreaking studies in T cell immunobiology, leading to discoveries such as the role of conformational changes in TCR activation. Dr. Alarcón has also been deeply involved in translational research, co-developing immunomodulatory drugs and securing patents that were licensed to Artax Biopharma. He regularly collaborates with leading immunologists and institutions worldwide, contributing to high-impact publications and international scientific reviews. His expertise and sustained contributions have made him a mentor and authority in molecular immunology and T cell biology.

🏅 Awards and Honors:

Dr. Balbino Alarcón’s distinguished career is highlighted by several prestigious awards and intellectual property recognitions. He co-developed two patented immunosuppressive strategies based on TCR signaling inhibition: one disrupting the TCR-Nck interaction and another involving chromene derivatives. Both patents were licensed to Artax Biopharma, showcasing the real-world therapeutic relevance of his research. He has authored highly cited publications, including foundational work published in Cell, Immunity, and Annual Review of Immunology, with citations in the hundreds. These contributions have not only advanced the field of immunology but also positioned Dr. Alarcón as a thought leader in immune signal transduction. He has been recognized nationally and internationally for his scientific achievements, serving as an editorial contributor and co-author of influential immunological reviews. His work continues to shape both academic and pharmaceutical research, making him a strong candidate for Best Researcher Awards.

🔬 Research Focus:

Dr. Alarcón’s research centers on the molecular mechanisms governing T cell receptor (TCR) activation and signal transduction. His work dissects how T cells recognize antigens and how intracellular signaling cascades translate these interactions into immune responses. A significant aspect of his research has involved understanding the conformational dynamics of the TCR/CD3 complex and how this affects T cell sensitivity and activation thresholds. He also explores the role of RRas2 in T and B cell function, including its relevance in lymphomagenesis and autoimmunity. Recently, he has contributed to understanding immune responses to SARS-CoV-2 and methods to detect neutralizing antibodies. His interdisciplinary approach integrates cell biology, molecular immunology, and translational research, linking fundamental science to clinical applications such as vaccine development and immunotherapy. By targeting TCR-associated pathways, Dr. Alarcón’s research opens new avenues in the treatment of immune-related diseases and cancer.

📚 Publications Top Notes:

  1. 🧫 RRas2 is required for germinal center formation to aid B cells during energetically demanding processes (Sci Signal, 2018)

  2. 🧪 A window of opportunity for cooperativity in the T Cell Receptor (Nat Commun, 2018)

  3. 🧬 Antigen phagocytosis by B cells is required for a potent humoral response (EMBO Rep, 2018)

  4. ⚙️ RRAS2 shapes the TCR repertoire by setting the threshold for negative selection (J Exp Med, 2019)

  5. 💊 Small molecule AX-024 targets T cell receptor signaling by disrupting CD3ε-Nck interaction (J Biol Chem, 2020)

  6. 🧪 Flow cytometry multiplexed method for the detection of Neutralizing human antibodies to SARS-CoV-2 (EMBO Mol Med, 2021)

  7. 🧬 Antigen presentation between T-cells drives Th17 polarization under limiting antigen (Cell Rep, 2021)

  8. 🧫 Detection of sustained humoral immune response (IgG + IgA) in SARS-CoV-2 infection (Sci Rep, 2021)

  9. 🧠 SFRP1 modulates astrocyte-to-microglia crosstalk in neuroinflammation (EMBO Rep, 2021)

  10. 💉 Longitudinal dynamics of SARS-CoV-2-specific immunity after infection or vaccination (PLoS Pathog, 2021)

🧾 Conclusion:

Dr. Balbino Alarcón is a highly deserving candidate for the Best Researcher Award. His pioneering studies in T cell signaling, impactful biomedical patents, and active role in immune response to infectious diseases demonstrate excellence in both basic and translational immunology. With decades of productive research, interdisciplinary collaboration, and consistent scientific leadership, he embodies the qualities celebrated by such an award.

Zhirong Tan | Gene Regulation Epigenetics | Best Researcher Award

Published on by Cell Biologist

Prof. Zhirong Tan | Gene Regulation Epigenetics | Best Researcher Award

Prof. Zhirong Tan  , Xiangya Hospital, Central South University , China

Professor Zhirong Tan is a leading Chinese expert in pharmacogenomics and clinical pharmacology. Currently a professor at Xiangya Hospital, Central South University, he also serves as the Director of the Pharmacogenetics and Pharmacokinetics Research Laboratory and Deputy Director of the Drug Analysis Center. He has been instrumental in over 300 clinical trials, pushing forward the frontiers of precision medicine, especially in colorectal cancer and Alzheimer’s disease. With over 20 SCI papers, multiple patents, and co-authorship of four books, he’s widely recognized for his work in pharmacokinetics and biomarker discovery. A national GCP and GMP inspector, Prof. Tan actively contributes to pharmaceutical regulation and innovation in China. His academic and industry partnerships reflect a robust foundation in translational research and real-world drug development.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Extensive Research Contributions
    Prof. Zhirong Tan has made outstanding contributions to clinical pharmacology, pharmacogenetics, and metabolomics over two decades. His research has provided critical insights into drug metabolism, biomarker discovery, and precision medicine, especially in colorectal cancer and Alzheimer’s disease.

  2. Prolific Publication Record
    With over 22 SCI-indexed publications (first or corresponding author) and 6 CSCD papers, Prof. Tan’s research has achieved over 3550 citations and an H-index of 33 on Web of Science—evidence of the high impact and recognition of his work.

  3. Strong National & Industry Collaborations
    He has participated in or led 300+ clinical trials and secured 5 “Million+” industry-funded projects, reflecting strong ties with both academia and industry. His leadership in national-level projects, such as the “Major New Drug Development” program, showcases his influence in China’s healthcare innovation.

  4. Intellectual Property and Innovation
    With 3 granted patents and 3 under review, Prof. Tan’s ability to translate research into practical applications is evident. His individualized esomeprazole dosing regimen highlights innovation at the clinical level.

  5. Regulatory & Policy Contributions
    As a national GCP/GMP inspector, he plays a pivotal role in drug trial ethics and compliance in China. He also holds leadership roles in pharmacogenomics committees, further demonstrating his commitment to public health advancement.

  6. Academic Mentorship and Editorial Work
    In addition to research, Prof. Tan contributes as a journal reviewer, co-author of four textbooks, and mentor to the next generation of scientists, reinforcing his role as a thought leader in the field.

🔍 Areas for Improvement:

  1. International Visibility
    While Prof. Tan’s national presence is remarkable, further international collaborations, invited keynotes at global conferences, or leading roles in global consortia could enhance his visibility and expand the influence of his work.

  2. Broader Publication Range
    Publishing more frequently in top-tier international journals (e.g., Nature, The Lancet, NEJM) would increase the global academic reach of his findings.

  3. Open Science & Data Sharing
    As the field moves toward transparency, incorporating open-access publications and shared data repositories could boost both reproducibility and citations.

🎓 Education:

Professor Zhirong Tan obtained his Ph.D. from Central South University, a premier Chinese institution, where he laid the groundwork for his expertise in clinical pharmacology and pharmacogenomics. He later pursued postdoctoral research at the School of Pharmacy, University of Maryland, Baltimore, one of the top pharmaceutical research institutions in the United States. This international experience enabled him to gain a global perspective in drug metabolism, biomarker identification, and translational pharmacology. His academic training focused on cutting-edge methodologies such as metabolomics, pharmacokinetics, and precision medicine. Through continuous education and research, he has built a reputation as a highly skilled pharmacologist whose work bridges basic research and clinical applications.

💼 Experience:

With a research career spanning over two decades since 1998, Professor Zhirong Tan has led and participated in numerous national-level and provincial-level projects, including China’s National Science and Technology Major Projects. He currently holds multiple leadership positions at Xiangya Hospital, Central South University. Over the years, he has completed major research grants from NSFC, the Hunan Province, and the Ministry of Science and Technology. As a GCP and GMP inspector, Prof. Tan has overseen more than 300 clinical trials, ensuring drug development meets regulatory and ethical standards. His experience also extends to industry collaboration, with successful execution of 5 “Million+” funded projects and influential roles in pharma-academic alliances. A frequent peer reviewer and contributor to international journals, his work influences both the scientific community and regulatory frameworks.

🔬 Research Focus:

Professor Tan’s primary research focus lies in clinical pharmacology, pharmacogenomics, and metabolomics, particularly for colorectal cancer and Alzheimer’s disease. His work aims to identify and validate biomarkers for disease diagnosis, drug efficacy, and toxicity prediction. A major contributor to China’s “Major New Drug Development” initiative, he has developed personalized esomeprazole dosing regimens by studying genetic polymorphisms, SNPs, and microRNA interactions. His research also explores the pathogenesis of Alzheimer’s disease using metabolomic profiling, offering insights into early detection and potential therapeutics. He applies advanced bioanalytical methods to understand inter-individual variability in drug metabolism and therapeutic response. His projects have real-world clinical implications, transforming how drugs are prescribed, regulated, and monitored. Through his pioneering work, Prof. Tan contributes significantly to the evolution of precision medicine in China.

📚 Publication Top Notes:

  1. 📊 Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

  2. ❤️ Gly389Arg polymorphism of β1‐adrenergic receptor and cardiovascular response to metoprolol

  3. 💊 CYP2C19 ultra-rapid metabolizer genotype affects voriconazole pharmacokinetics

  4. 🧬 HLA‐B35:01 allele as biomarker for Polygonum multiflorum–induced liver injury*

  5. 🌿 Repeated berberine administration inhibits cytochromes P450 in humans

  6. 💉 Effect of SLCO1B1 polymorphism on pharmacokinetics of nateglinide

  7. 🧪 Assessment of cytochrome P450 activity by five‐drug cocktail approach

  8. ☕ Plasma caffeine metabolite ratio linked to CYP1A2 polymorphisms

  9. 🔬 Inducibility of CYP1A2 by omeprazole associated with genetic polymorphism

  10. 🧫 Ile118Val polymorphism of CYP3A4 affects simvastatin lipid-lowering efficacy

📝 Conclusion:

Professor Zhirong Tan is a highly deserving candidate for the Best Researcher Award. His record of scientific excellence, clinical innovation, and regulatory leadership clearly positions him as a key contributor to modern pharmacology. His integrated approach—spanning basic science, clinical trials, and health policy—has had a measurable impact on patient care and drug development in China.

While there is room to further expand his global footprint, his accomplishments to date already demonstrate the caliber, commitment, and consistency expected of a world-class researcher.